SCHEMBL247775

SCHEMBL247775

NC(=O)C[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)NCC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.44
GSTK1 Q9Y2Q3 1/20 0.44
GLO1 Q04760 2/20 0.39
ECE1 P42892 5/20 0.39
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
PTGS2 P35354 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PDCD1LG2 Q9BQ51 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
MMP8 P22894 1/20 0.37
CTSD P07339 1/20 0.35
BACE1 P56817 1/20 0.35
DPP4 P27487 1/20 0.34
DPP8 Q6V1X1 1/20 0.34
DPP9 Q86TI2 1/20 0.34
OPRD1 P41143 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7981504 0.98 PTGS1 (0.43) PTGS1GSTK1GLO1ECE1ALDH1A1
SCHEMBL8071951 0.98 PTGS1 (0.43) PTGS1GSTK1GLO1ECE1ALDH1A1
SCHEMBL8128334 0.98 PTGS1 (0.43) PTGS1GSTK1GLO1ECE1ALDH1A1
SCHEMBL6902897 0.98 PTGS1 (0.43) PTGS1GSTK1GLO1ECE1ALDH1A1
SCHEMBL1444095 0.98 PTGS1 (0.43) PTGS1GSTK1GLO1ECE1ALDH1A1
SCHEMBL901171 0.94 PTGS1 (0.47) PTGS1GSTK1GLO1ECE1PDCD1LG2
SCHEMBL8045766 0.94 PTGS1 (0.44) PTGS1GSTK1GLO1ECE1ALDH1A1
SCHEMBL4260374 0.94 PTGS1 (0.44) PTGS1GSTK1GLO1ECE1ALDH1A1
SCHEMBL1472487 0.94 PTGS1 (0.44) PTGS1GSTK1GLO1ECE1ALDH1A1
SCHEMBL6831118 0.93 PTGS1 (0.43) PTGS1GSTK1GLO1ECE1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9741 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106589134-B Chimeric protein pAgoE, construction method and application thereof, chimeric protein pAgoE using guide, construction method and application thereof 仪宏 2021-04-20 CN claimed
CN-111454331-A Polypeptide and application thereof 武汉原生药谷生物医药科技有限公司 2020-07-28 CN claimed
CN-111454368-A Construction method and application of small-molecule anti-TNF- α therapeutic antibody 武汉原生药谷生物医药科技有限公司 2020-07-28 CN claimed
WO-2019004878-A1 PREPARATION OF WHEAT CYSTEINE PROTEASE TRITICAIN-ALPHA PRODUCED IN SOLUBLE FORM AND METHOD OF PRODUCING SAME федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) 2019-01-03 WO claimed
EP-1824514-B1 TOLL LIKE RECEPTOR 3 ANTAGONISTS, METHODS AND USES JANSSEN BIOTECH INC (US) 2015-03-04 EP claimed
CN-103725698-A Surface protein ClfA gene segment of chemically-synthesized staphylococcus aureus as well as expression and application of surface protein ClfA gene segment LI YUEXI 2014-04-16 CN claimed
US-20120189643-A1 Toll Like Receptor 3 Antagonists, Methods and Uses CARTON JILL M (US) 2012-07-26 US claimed
CN-102559688-A TPR structural motifs and cellular localization of swine ISG60 gene associated with antiviral immunity UNIV GUANGXI 2012-07-11 CN claimed
CN-102161703-A Method for preparing monoclonal antibody resisting human neuropilin-1 UNIV XIAMEN 2011-08-24 CN claimed
JP-4267923-B2 2009-05-27 JP claimed
US-4975369-A DNA SEQUENCES ELI LILLY AND COMPANY (US) 1990-12-04 US claimed
WO-1990013634-A2 ENZYMES AND THEIR USE IN DRUG DETECTION NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1990-11-15 WO claimed
WO-1990012097-A1 RECOMBINANT TRICHOSANTHIN AND CODING SEQUENCE GENELABS INCORPORATED (US) 1990-10-18 WO claimed
CN-1037174-A At antigenic new reorganization of human adenocarcinoma and chimeric antibody LILLY CO ELI (US) 1989-11-15 CN claimed
EP-0292435-A1 Zea mays plants and transgenic zea mays plants regenerated from protoplasts or protoplast-derived cells CIBA-GEIGY AG (CH) 1988-11-23 EP claimed
EP-0275305-A4 DNA SEQUENCES CODING FOR MODIFIED FACTOR VIII:C AND MODIFIED FACTOR VIII:C-LIKE POLYPEPTIDES AND PROCESSES FOR PRODUCING THESE POLYPEPTIDES IN HIGH YIELDS. BIOGEN NV (NL) 1988-11-07 EP claimed
EP-0275305-A1 DNA SEQUENCES CODING FOR MODIFIED FACTOR VIII:C AND MODIFIED FACTOR VIII:C-LIKE POLYPEPTIDES AND PROCESSES FOR PRODUCING THESE POLYPEPTIDES IN HIGH YIELDS BIOGEN, INC. (US) 1988-07-27 EP claimed
EP-0273800-A2 Hirudine variants, their use and preparation TRANSGENE S.A. (FR) 1988-07-06 EP claimed
WO-1988000831-A1 DNA SEQUENCES CODING FOR MODIFIED FACTOR VIII:C AND MODIFIED FACTOR VIII:C-LIKE POLYPEPTIDES AND PROCESSES FOR PRODUCING THESE POLYPEPTIDES IN HIGH YIELDS BIOGEN N.V. (AN) 1988-02-11 WO claimed
WO-1985004418-A1 VECTORS FOR THE EXPRESSION OF HIRUDINE, TRANSFORMED CELLS AND PROCESS FOR THE PREPARATION OF HIRUDINE TRANSGENE S.A. (FR) 1985-10-10 WO claimed